Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“BOD, NP: complete the story & BLA, close the deal and render CYDY as a real biotech company with a real drug”.
Been saying this for the last year. Bite the F#%g bullet and secure financing to get us to BLA completion and FDA approval.
Nothing new, as is so predictable, Nader will continue to believe the big deal is a couple of weeks away and raise pennies. He does not have a clear sense of reality —period. BP continues to watch and wait for a bottom feeding opportunity.
That is our number one Risk — the man at the controls.
Yes, we are of the same mind. If this turns out to be a 5x or a dreaming 10x it will be the most taxing investment winner of my life. You will not see me invested in another OTC stock. If I’ve learned one thing it’s that regardless of how good the science is, it can still be worthless if not managed correctly.
I couldn’t help but chuckle at Nader’s exuberance while trying to put an understandable sentence together. Even Christine appeared on the cusp of busting up. And yes the questions would appear to be those that everyone wants answered on IHub.
It would be a moment for the ages for us all if Nader actually delivers this time. I find it unfathomable that Nader would make the announcements he’s making if he could not come through. I mean this is by far the furthest out on a limb he has ever gone.
So either desperation has provoked insane recklessness or he’s going to deliver. What a pivotal point for our investment - not delivering would be crushing.
You want me to fess up and take credit for something I didn’t write. Sorry, that not who I am.
I couldn’t be happier to see the SP up. I’ve got over 500k shares and am down 35%. You think I want to see this nose dive? I want this to succeed.
However I am disappointed in Nader’s strategy, effectiveness, communication skills, overpromising and never delivering, and leadership for a short list.
JMO, thanks for your mistaken credit on the SA article.
You think I wrote that article. I don’t write for SA or any other forms of third party media.
Lmao
“And if the deal doesn’t occur, it won’t be the end of the world – – just the end of NP’s credibility given his very specific guidance.”
You sum up my perspective perfectly although I would say he is already at the end of his credibility. The Nader dance cannot be ignored any longer. Put up or shut up and know your job is on the line. Yes, the BOD is in love with Nader because it’s convenient and he knows Leronlimab inside and out. That love won’t continue w/o results. Like you my money is hard earned and I want more competent representation and performance.
I am very bullish on the long term prospects but I refuse to have my head in the sand.
Yes, if Nader comes through his stock goes up and his runway is much longer. Out of runway if he does not.
The concern is why would this be any different. We will have our answer in the coming weeks and I’m hoping he comes through. However
I’m mentally prepared for a repeat and the difficult decisions that will need to be made in order to salvage this investment.
You are mistaken if you think BP does not know about Cytodyn and Leronlimab. This is not about being known. We are known.
This is about a professional approach that understands the process and protocol to attract interested suitors and close the deal.
Let’s see if Nader can somehow accomplish this with his approach in the coming weeks. Understand I’m rooting for him-not against him.
I just think he is a liability in this environment. The definition of insanity is doing the same thing over and over again and expecting a different result.
Fact is Nader’s runway, depending on opinion is either:
In great shape
Getting shorter
Running out
Gone
Or
Has been gone
“Like it or not, NP knows more about where we’ve been, where we are, and where we’re going, and that is not something I’m comfortable with changing.”
Always respect your opinions Bulldog. I agree with your above opinion except where we are going.
He may think he knows where we are going unfortunately his strategy to get there combined with his skill set is not something I’m willing to buy into. My issue is with his strategy, methodology, and ability. IMHO If we remain blind to the obvious we will end up wondering why we were so blind.
Sometimes we are to close to the fire to be objective. How long does this story have to survive if we continue with this type of strategy and leadership? We can bank on the power off the science - but even this science if not massaged and managed correctly can wind up in a severely negatively leveraged position. From my perspective we are dangerously close and will be crossing the line if Nader fails on his latest promise.
The plummeting SP is the proof of just how serious our predicament is. We would be fools to underestimate the current state of finances.
Nothing is static newrunner.
I understand your inquiry Misiu. I respect you as a healthcare professional, a person of humility and one that demonstrates respect.
To fully answer your question would take more time than I have. I will give you my best short version.
My shift is a result of Nader‘s track record, inflated story telling, and continually coming up short on his promises. It started with the Golden Quarter and has continued for years. His communication skills and persona are dangerous and non conducive in terms of what is needed. There are reasons for our current predicament and how we got here and possess a .30 SP.
Nader was the right CEO for his run. He has campaigned with all his heart to fund the science. He was good at it. He raised a couple hundred million on his watch. I applaud his tenacity. He rode the Paulson horse hard and squeezed all he could.
He advanced the science although it has been quite bumpy and much time has been wasted as witnessed by the continual delaying of completing the BLA. The FDA is not delaying the BLA, poor allocation of resources on Nader’s part has been the culprit. Remember it’s a rolling BLA. The entire BLA could have been submitted and the stability data could be added when it was available. Resources were not focused on the BLA. Point is we would be six months ahead.
As companies evolve different types of experience and skills are needed from a CEO. It is not feasible to commercialize on our own. If we don’t bring a seasoned CEO with the horsepower and expertise to negotiate a deal to get this molecule handed off the possibility of severely or totally compromising our ROI is very real.
People will say that person is not out there. That is not true. There are many qualified CEO’s that would jump at the opportunity because of where we are in the development of Leronlimab. Are they expensive? Yes, but not near as expensive as the alternative if a change is not made.
There is also a disconnect in that Nader does not sleep in the same bed as the shareholders as he has not purchased any stock. He does not have the same skin in the game and is able to collect an inflated salary. His urgency is different than the shareholder-that is a big negative.
You must understand the clock is ticking and we are not the only company pursuing the CCR5 pathway. We have serious value in the HIV space and the Mono data is approaching a point in time where it’s not fiction it’s fact and BP will jump if the data is presented in a format that they require so they can make an educated decision - and we have the Cancer play as a bonus. It is imperative that our representation at the negotiating table speak the same language as those that sit across the table.
I appreciate all that Nader has done however he does not possess these skills. There is nothing more dangerous then the equation we have right now. Nader thinks he knows everything — IMO he does not and is way out of his league. Nader’s track record speaks volumes in terms of the way he communicates. He is arrogant and unwilling to listen. He shuts anybody and everybody down that does not agree with him. What do you think happened with Pestell? To fire Pestell was a major tell and a huge mistake regardless of what transpired.
Keep him through the completion of the BLA if he gets his touted deal that is supposed to transpire any day. If we get into the middle of November and there is no deal replace him now rather than later.
This isn’t personal it’s business and this is the big dance and we need a professional that understands the landscape and is honest with his shareholders.
There is no question that even with Nader consummating the much anticipated and hoped for deal his days are numbered. In addition this has become Nader’s paternal baby making him far to emotional. The days ahead require a different skill set and it doesn’t take rocket science to figure that out.
The BOD is going to have to grow a pair and step up and do what is best for the shareholders and we as shareholders should voice our opinions to the BOD. The BOD’s responsibility is to serve the best interests of its shareholders. The time is coming where critical and difficult decisions will need to be made for a successful conclusion to this investment.
I have a pretty good idea how much desperation Nader and the BOD is feeling. With the current SP and upside down balance sheet I can assure you there is some serious pressure to close a deal. Understand Paulson is dry and that is where Nader goes when he comes up dry. Not this time. Their is big time urgency.
As for the Voice analogy you have to get a chair to turn and Nader has not been able to make it happen. His competency is a big question mark in the deal making front.
Let me be straight. I am all in and not selling. I am far less confident in Nader taking this across the finish line than I was 6 months ago. He has to deliver to make me a believer.
Ohm20,
“You seem to be forgetting the current one being hammered out. If it comes to fruition it is far superior to a $5 a share buyout.”
With all due respect you seem to forget I have been invested for six plus years and supported Nader. You on the other hand have not been exposed to the redundancy of the Nader dance.
He is batting 100% - he has made many promises and has not delivered once. Excuse me if I’m a bit jaded when it comes to the thin air he spews. The manner in which he has leaked this supposed deal he is negotiating is a tell. It lacks any type of professionalism and wreaks of the way he plays the retail investor.
As I said previously, “ I will eat my words joyously if I am wrong”. Oh how I hope I am wrong.
A17,
You bring up good points.
“NP just does not have skills, experience or capability to take the product to market.
In fact I am doubtful if his BLA submission will be clean enough to get approval in first round even after rolling BLA. “
I know that Nader will have the final BLA Package reviewed by an outside source to insure all of the boxes have been checked. If he were to submit an unacceptable package that would cost us another six months which we do not have. That too cost $. Plane and simple lack of $ is delaying the completion of the BLA.
Nader made a critical miscalculation by perusing the Cancer indications rather than devoting all resources to completing the BLA. He has left himself in a corner in terms of financing.
I agrees that Nader lacks the skills and has no credibility. He has proven this. I will eat my words joyously if he pulls off the deal he is currently touting. My gut feeling is why would this turn out any differently than anything of his previous promises? He has been consistently unable to deliver sense the infamous Golden Quarter he so gregariously promised.
Couldn’t agree more.
And to the CEO NP, no, it is not $5 -$10 for Combo alone as of today.
If you get an offer for $2+ for Combo - take it.
If you get an offer for $5+ for the whole company - take it.
Nader has run us into a corner because of his unrealistic valuation.
His arrogance and ignorance is a growing concern as he has proven to be quite ineffective in attracting a deal of any kind. It’s been toxic Paulson for years and now that well is dry. Is Nader the elephant in the room?
I feel your pain BH. IMO most Long’s are growing increasingly impatient with Nader’s style, inflated compensation, shrinking SP, and inability to deliver on a financial deal that could get us over the hump.
I’m of the opinion that it would be wise to take the best deal on the table with the most upfront cash —maybe that deal is in the works right now. That would get us to FDA approval for HIV Combo. Then we have the ability to begin commercializing and generating revenue, push the Mono and TNBC trials and hopefully get the interim data we believe is there.
Point is I think Nader should get real about Leronlimab’s CURRENT valuation rather than constantly pitching the valuation that is just around the corner. Nobody is buying his worn out story and the SP is proof. The result is a dirt road that continues to get longer and wider with no money to pave any part of it.
Hopefully his latest words deliver. Problem is we have been doing this dance for years and one becomes numb to believing this will be any different than the golden quarter that was promised years ago.
Science is still stronger than ever. Progress is confined to an empty bank account.
Well said Misiu.
At some point it is wiser to bite the bullet and get the show on the road rather than continuing to hold out for what seems to be fair and reasonable. Fair and reasonable is an agreement by both sides in terms of where Leronlimab is in the development process.
Obviously Nader thinks he can command a much higher price if we have the BLA completed and interim from a few TNBC patients. That may be so but how long are we going to draw this out moving at a snails pace. We need $ to get this across the finish line. I’m tired of dicking around.
It’s all about the terms. Nader refuses to get raped. Problem is we are all tired of playing the waiting game on some real money saying we believe in Leronlimab.
Grip, you need to get a grip. Your welcome to your opinion but you sound like an angry child. The glass is obviously half empty from your perspective. That doesn’t mean you are now a prophet. While I’m growing impatient with Nader it’s difficult to say he’s worthless. He’s got a strong team of seasoned docs that have bought into Leronlimab’s science and it is moving forward.
The game plan is to focus on devoting our limited finances to completing the BLA. They believe that’s the time to go for a deal as they will also have Interim for TNBC. Until then no bottom fishing will be accepted. It’s a chess game and Nader isn’t going to cave. Whether this turns out to be a wise move remains to be seen. We might just agree with every move he’s making if we had the same inside info. We don’t so we have no choice but to remain positive and see this through.
Well stated Finesand. You have stated our current predicament quite concisely.
I understand Nader and the BOD’s strategy to advance the science by just raising enough to get to the inflection point so as to maximize SH ROI. That strategy has for the most part been unsuccessful. Progress has moved at a snails pace because of lack of capital and the SP has been destroyed with the warrant driven raises. For Nader to continue stating that raising money has never been a problem is just pure BS.
It’s now time to face reality. The vehicle we are driving with the gold in the trunk is out of gas and needs major repairs to make it to the security vaults. Time to protect the cargo. Trade a chunk of equity for the capital infusion and support that is needed to insure we get to the finish line. This is no time to get greedy and yes Nader’s Cockiness is a concern.
Agreed. There comes a point when Nader has to deliver. I have listened to him say we are right there in terms of the finish line for three years. Put up or shut up. I am not happy with him continually going back to the Paulson well. It’s dry.
I have no doubt Nader is a hard working man. Does he work smart? Does he have the moxie to bring this home? Certainly fallen short up to this juncture. Nader’s inability to cut the cord with Paulson is both eroding the SP and strangling the company.
In the end none of this will matter if he closes the deal. That will allow the breathing room to complete the BLA, get the Mono trial moving, and advances the cancer trials.
If he doesn’t? Well, we are witnessing the alternative; a plunging SP that will make it even more difficult to ink any kind of reasonable deal.
Where is Dr. Rae? He’s the seasoned deal maker.
Did I not say that?
“NP putting a catalyst (or hurdle) right in front of himself (the deal),
only to either fly over or stumble with broken legs?”
Yes he has set the perfect trap for himself. Or has he set the stage to shock shareholders with finally doing what he said he would when he said he would do it.
The market says I’ll believe it when it is finalized with a PR. Not a lot of wiggle room left for the master wiggler.
Exactly right Plavac.
You obviously know very little about Nader other than what you’ve gleaned from posters here on IH.
If you think Nader is in this to collect his salary and purposely screw the SH’s then exit now.
I can tell you that is not what is going on here. Naders compensation is one issue as well as his effectiveness as CEO. His intent is to maximize ROI for all that have skin in the game. He would gladly relinquish his salary for a reasonable buy-out. End of story.
Grip, IMO selling would be a monumental mistake that you would have to live with the rest of your life. While I am frustrated with Nader’s misleading, over promise dialogue I firmly believe the power of the science is more than worth the current risk associated with Nader’s perceived incompetence.
Nader wants what we all want, a deal that represents the maximum value for a molecule that is DEVELOPING a pipeline of multiple indications. The BOD supports this strategy of moving as many indications as possible into position for P2 clinical trials. They believe if the TNBC P2 data comes back similar to the mice models, Leronlimab’s value will be increased dramatically with all the other indications in position for trials. That makes logical sense and I’m sure most here would agree.
Here’s my rub with Nader and the BOD. Time is going by and we have the secret sauce. The secret sauce is worthless without the horsepower to advance the clinical data and commercialize. It’s time to sacrifice a chunk of equity to get to the finish line. Knowing what we have has been our own worst enemy because the valuation placed on the secret sauce is not in line with the current stage of advancement of the clinical data. The market has spoken.
Nader has a signed MOA on $90M non binding deal. That sounds quite enticing, however the devil is in the details. Frankly, I think we have reached a pivotal point in time in which Nader must make the deal work. What are the options? Bump along with an empty bank account delaying the BLA and trials that are the only way to increase value. Here this loud and clear Nader and BOD’s; we can’t have our cake and eat it too at this juncture in time. We need major financing to go where we need to go to get to the finish line. Cut the deal before you run Leronlimab into a ditch because nobody would pay your asking price.
Plain and simple it’s worth what we can get right now. You’ve got the MOA, they are serious. Do your job and bring it home so we have the resources to right the ship. We don’t have time to burn another year waiting for the perfect deal.
Nader is so slippery. Listening to him talk about the the non-binding MOA makes me even more cautious about this deal reaching any type of completion in five weeks. I’ve just heard this dialogue and sales hype too many times. He is the master of creating hope. Hope is the greatest tool in a salesman’s arsenal because it always relates to the future not the present. The present is about facts while the future is left up to dreams and interpretation. Nader lives in that space which has huge wiggle room.
He claims he just wants to provide clear communication with the SH’s. The reality is his communication is not straight forward it is always a trumped up sales pitch that never comes to fruition.
If Nader inks the $90M deal he has pitched I will humbly change my tune. My issue is Nader can’t continually pitch and not deliver and expect SH’s to respect and believe in his leadership.
IMO the current SP demonstrates that the market sees it the same way.
I’m ready to watch the show...but please no more S%#t Show. Having converted all my Warrants with the Tender Offer I’m loaded. Sure, I may regret not getting greedy at prices like these but I can’t in good conscious place any more weight here.
Good to see your back on the Bullish track. Hopefully it’s for good this time, although you have a track record that is quite volatile so it would not surprise me if the next bump derails your current perspective. By all means do what you must, I for one am not offended by opinion. It has no bearing on where this investment will end up playing out.
Agreed Blueheel. I’m a very patient person but I have to admit after six plus years my patience is being tested.
I follow the board but have recently cut back on posting and following every micro move because I’ve become a bit numb to Nader’s promises. I just want to wake up and read the PR that Nader has finally delivered what he has promised. Then we can get on with completing the BLA and advancing the Cancer play which should lead to a buy out.
For the record I would take $5 a share today and walk. Maybe we get much more or maybe we continue to do the smoke and mirrors Nader dance and wash this compelling science right down the drain. That is my only fear - Nader driving this investment right into the ground. As much as I have backed Nader because of his passion and tenacity I have drifted into Lawman’s camp because of Nader’s track record. It simply can’t be ignored. I hope all this is put to rest in five weeks when we get what Nader has so passionately described.
I’m ready to put this in my rear view mirror and move on.
“The Paulson days are over”
Blueheel, I have been dreaming of that day for too long. I have foolishly trusted Nader’s exuberance too many times. Every time I think it’s around the corner it’s another long block. I see it very clearly in that it’s time for Nader to deliver and the market sees it the same way... clinging to .40. Cut the deal and advance the science NOW.
Anyone with common sense that follows and understands Nader’s past performance realizes its time to put up or shut up. I am cautiously optimistic about the binding deal on the table but like Lawman have my reservations.
The SP is tightly controlled by the Paulson investment crowd that purchases for one reason; dump the shares and build their risk free warrant position. They eliminate all risk and are not interested in the POTENTIAL upside. It’s a business and they are disciplined.
I have participated in multiple Paulson raises as have many here on the board. The difference is this group for the most part holds both their shares and Warrants (and even takes advantage of the Tender Offer concerting their Warrants) because of the science and massive upside potential.
When will this cycle change? Either when the cheap shares are gone or a major event. Until Nader completes the deal and “non-binding” is removed this is viewed as a non-event to the market. If Nader delivers will this be the major event that breaks the cycle?
Money talks and Bullshit walks.
Scott is heavily invested with his own $. He eatS sleeps and breathes CYDY. Tremendous passion and belief in the future of this molecule.
Rab, I have been out of pocket traveling in Asia on business so I haven’t read all the details on the Pestell mess, just the posts on IHUB.
I will say this I certainly don’t like that Pestell had to be terminated. There is no way we can paint this as a positive event. My gut tells me there was just cause as Nader had to have the consensus of the BOD, as he doesn’t have the power to act alone. He was man enough to take responsibility for Pestell’s performance or lack thereof.
Lots of speculation here by people that are not in the know and that is rarely ever accurate. Especially Fines unending crystal ball, told you so rant.
Pestell is asking for $1.3M and using that to protect the 8M shares that are exposed. To me that doesn’t compromise CYDY’s financial position as it could mean 8M shares taken back.
Bottom line is everybody will flow with the financing card that Nader continues to talk up but is yet to deliver. That is really all that matters at the moment. The heat is on Nader to deliver and the Pestell lawsuit isn’t going to scare potentials away. The science is what it is and BP could care less about this side show.
JMHO